Webinars

Download and learn from our latest pharmaceutical development webinars.

Recent Webinars

505(b)(2) Regulatory Planning: Designing Streamlined Programs to Create Value for Patients and Sponsors

505(b)(2) Regulatory Planning: Designing Streamlined Programs to Create Value for Patients and Sponsors Date: September...

How Commercial Insights Can be Used to Maximize an Early Exit

How Commercial Insights Can be Used to Maximize an Early Exit Date: August 25, 2021...

The Pediatric Research Equity Act (PREA) and Its Implications for Oncology Development

The Pediatric Research Equity Act (PREA) and Its Implications for Oncology Development Date: June 29,...

Challenges and Opportunities in Rare Pediatric Drug Development

Challenges and Opportunities in Rare Pediatric Drug Development From World Orphan Drug Congress 2021 Date: April...

Achieving Long-Term Success for Your Development Program — Mike Dial and Tim Sullivan

Achieving Long-Term Success for Your Development Program Advice from Industry Experts for Early-stage Sponsors, Part...

Achieving Long-Term Success for Your Development Program — Mark McCamish

Achieving Long-Term Success for Your Development Program Advice from Industry Experts for Early-stage Sponsors, Part...

505(b)(2) Regulatory Planning: Designing Streamlined Programs to Create Value for Patients and Sponsors

505(b)(2) Regulatory Planning: Designing Streamlined Programs to Create Value for Patients and Sponsors Date: September...

The Value of Real World data in Orphan and 505(b)(2) Drug Development

DownloadDate: October 9th, 2019 Presented by: Ken Phelps, president and co-founder, Camargo In orphan drug...

The 505(b)(2) Pathway: Getting to the Clinic Faster

Download Date: July 17th, 2019 Presented by: Ken Phelps, president and co-founder, Camargo You’ve identified your product...

The 505(b)(2) Pathway: What is it? And What Does it Mean for Pre-IND and NDA Submission?

DownloadDate: May 29th, 2019 Presented by: Ken Phelps, president and co-founder, Camargo To bring a new drug...

The Early Stage Therapeutics Investors Panel

View Date: September 26th, 2017 Location: RESI in Boston, Massachusetts Presented by: Ken Phelps, president and co-founder, Camargo

Early 505(b)(2) Strategy for Long-term Success

View Date: June 19th, 2017 Location: RESI in San Diego, California Presented by: Ken Phelps, president and co-founder,...

505(b)(2), Why Now? With Hands On the Project Case Study

Download Date: January 2nd, 2017 Location: DCAT Week 2017 Presented by: Ken Phelps, president and co-founder, Camargo, with...

How to Use 505(b)(2) to Achieve Commercial Success

Date: November 30th, 2016 Location: FierceLive! Webinars Presented by: Ken Phelps, president and co-founder, Camargo